New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
08:06 EDTBDXBecton Dickinson receives FDA clearance to market BD MAX StaphSR assay
BD Diagnostics, a segment of Becton Dickinson, announced it has received FDA clearance to market the BD MAX StaphSR Assay for use on the fully-automated BD MAX System. The assay, with eXTended Detection Technology, detects Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA directly from nasal swabs, including mecA dropout mutants and new strains of MRSA that may not be detected by other assays.
News For BDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
16:37 EDTBDXBecton Dickinson acquires CRISI Medical Systems
Becton Dickinson announced the acquisition of CRISI Medical Systems, a San Diego-based medical technology company dedicated to improving the safety and delivery of IV injectable medications. The acquisition furthers BD's position in helping address preventable medication errors and improve care delivery efficiencies. Financial details on the acquisition are not being disclosed at this time. BD expects the transaction will be immaterial and does not expect it to impact BD's previously communicated FY15 earnings guidance.
February 20, 2015
15:09 EDTBDXBecton Dickinson management to meet with JPMorgan
Meetings to be held in New York on February 24 and in Atlanta on February 25 hosted by JPMorgan.
February 17, 2015
15:15 EDTBDXBecton Dickinson management to meet with William Blair
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use